Two compounds commonly used for phospholipase C inhibition activate the nuclear estrogen receptors

Biochemical and Biophysical Research Communications

Volumn 261, Issue 2, 1999, Pages 340-344

  Cenni, Bruno ^a   Picard, Didier ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR;

ARTICLE; CHEMICAL STRUCTURE; DEGRADATION; HUMAN; HUMAN CELL; METABOLISM; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0033516981     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1999.1017     Document Type: Article

References (23)

1. Rhee S. G., Bae Y. S. J. Biol. Chem. 272:1997;15045-15048.
2. Smith R. J., Sam L. M., Justen J. M., Bundy G. L., Bala G. A., Bleasdale J. E. J. Pharmacol. Exp. Ther. 253:1990;688-697.
3. Bleasdale J. E., Thakur N. R., Gremban R. S., Bundy G. L., Fitzpatrick F. A., Smith R. J., Bunting S. J. Pharmacol. Exp. Ther. 255:1990;756-768.
4. Bosch R. R., Patel A. M., Van Emst-de Vries S. E., Smeets R. L., De Pont J. J., Willems P. H. Eur. J. Pharmacol. 346:1998;345-351.
5. Pulcinelli F. M., Gresele P., Bonuglia M., Gazzaniga P. P. Biochem. Pharmacol. 56:1998;1481-1484.
6. Jin W., Lo T. M., Loh H. H., Thayer S. A. Brain Res. 642:1994;237-243.
7. Torchia J., Glass C., Rosenfeld M. G. Curr. Opin. Cell Biol. 10:1998;373-383.
8. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P. Cell. 83:1995;835-839.
9. Ekena K., Katzenellenbogen J. A., Katzenellenbogen B. S. J. Biol. Chem. 273:1998;693-699.
10. Kuiper G. G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J. A. Endocrinology. 138:1997;863-870.
11. Davidson N. E. Curr. Opin. Oncol. 10:1998;475-478.
12. Cenni B., Picard D. Trends Endocrin. Met. 10:1999;41-46.
13. Trempe G. L. Recent Results Cancer Res. 57:1976;33-41.
14. Picard D., Salser S. J., Yamamoto K. R. Cell. 54:1988;1073-1080.
15. Tora L., Mullick A., Metzger D., Ponglikitmongkol M., Park I., Chambon P. EMBO J. 8:1989;1981-1986.
16. Green S., Walter P., Kumar V., Krust A., Bornert J. M., Argos P., Chambon P. Nature. 320:1986;134-139.
17. Bunone G., Briand P. A., Miksicek R. J., Picard D. EMBO J. 15:1996;2174-2183.
18. Kumar V., Green S., Stack G., Berry M., Jin J. R., Chambon P. Cell. 51:1987;941-951.
19. Kalkhoven E., Valentine J. E., Heery D. M., Parker M. G. EMBO J. 17:1998;232-243.
20. Ekena K., Weis K. E., Katzenellenbogen J. A., Katzenellenbogen B. S. J. Biol. Chem. 271:1996;20053-20059.
21. Schwertz D. W., Kreisberg J. I., Venkatachalam M. A. J. Pharmacol. Exp. Ther. 231:1984;48-55.
22. Carney D. H., Scott D. L., Gordon E. A., LaBelle E. F. Cell. 42:1985;479-488.
23. Guengerich F. P. Trends Pharmacol. Sci. 10:1989;107-109.